August 18 (SeeNews) - The Bulgarian Stock Exchange (BSE) said that it admitted to trading a 5 million euro ($5.45 million) bond issue of local medical consumables trader Bioiasis [BUL:BIOA].
The securities will start trading under the code BIOB on August 22, the BSE said in a statement on Thursday. The final trading date is March 31, 2031.
The indicative reference price for the first trading session is set at 100% of the bonds' nominal value.
In April, Bioiasis issued 5,000 bonds with a par value of 1,000 euro each, due on April 6, 2031. The bonds have a floating annual coupon rate based on the six-month EURIBOR plus 1%, but not less than 3% and not more than 5.5%, with payments due semi-annually.
Shares in Bioiasis last traded at 16.08 levs ($8.96/8.22 euro) on the BaSE market of the Bulgarian Stock Exchange, bourse data show.
($ = 0.9174 euro)